Difficulty: Medium
Average Score: 72%
Practice
Which of the following drug is contraindicated in myasthenia gravis?
Correct answer
C
Rationale
In the context of pharmacology, understanding drug contraindications is crucial to ensure safe and effective patient care. In the case of myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and fatigue, certain medications can exacerbate symptoms and lead to serious complications. Quinine, the correct answer, is contraindicated in myasthenia gravis due to its potential to worsen muscle weakness and respiratory function in these patients.
Neostigmine and pyridostigmine, options A and B, are acetylcholinesterase inhibitors commonly used in the treatment of myasthenia gravis to improve muscle strength by increasing acetylcholine levels at the neuromuscular junction. These drugs work by prolonging the action of acetylcholine, thereby enhancing muscle contractions. Therefore, they are not contraindicated but actually indicated in myasthenia gravis.
Ephedrine, option D, is a sympathomimetic amine that acts on adrenergic receptors to stimulate the release of norepinephrine. While ephedrine is not a first-line treatment for myasthenia gravis, it is not specifically contraindicated in this condition. However, caution should be exercised when using sympathomimetic agents in patients with myasthenia gravis due to potential interactions with other medications and the risk of exacerbating symptoms.
Educationally, this question highlights the importance of understanding drug contraindications in specific patient populations. By knowing which medications to avoid in conditions like myasthenia gravis, healthcare providers can prevent adverse drug reactions and optimize patient outcomes. This knowledge is essential for pharmacology students, nurses, pharmacists, and other healthcare professionals involved in medication management and patient care.
Neostigmine and pyridostigmine, options A and B, are acetylcholinesterase inhibitors commonly used in the treatment of myasthenia gravis to improve muscle strength by increasing acetylcholine levels at the neuromuscular junction. These drugs work by prolonging the action of acetylcholine, thereby enhancing muscle contractions. Therefore, they are not contraindicated but actually indicated in myasthenia gravis.
Ephedrine, option D, is a sympathomimetic amine that acts on adrenergic receptors to stimulate the release of norepinephrine. While ephedrine is not a first-line treatment for myasthenia gravis, it is not specifically contraindicated in this condition. However, caution should be exercised when using sympathomimetic agents in patients with myasthenia gravis due to potential interactions with other medications and the risk of exacerbating symptoms.
Educationally, this question highlights the importance of understanding drug contraindications in specific patient populations. By knowing which medications to avoid in conditions like myasthenia gravis, healthcare providers can prevent adverse drug reactions and optimize patient outcomes. This knowledge is essential for pharmacology students, nurses, pharmacists, and other healthcare professionals involved in medication management and patient care.